Ritodrine Hydrochloride interactions
Checked as Ritodrine in this data source.
Full monograph for Ritodrine HydrochlorideCheck it against another medicine
Medicines
308 documented
Mechanism
| Medicine | Severity | Mechanism | Effect | Sources |
|---|---|---|---|---|
| Amiodarone Hydrochloride | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that… | 27 sources — open the full entry |
| Amisulpride | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that… | 27 sources — open the full entry |
| Amlodipine Besilate + Atenolol | Major | Antagonism | The use of a nonselective beta blocker with ritodrine (a beta-2 agonist) may result in mutually antagonistic effects, negating the effect of one or both drugs. | 1 sources — open the full entry |
| Arsenic Trioxide | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that… | 27 sources — open the full entry |
| Artemether + Lumefantrine | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that…2 documented mechanisms | 54 sources — open the full entry |
| Atenolol | Major | Antagonism | The use of a nonselective beta blocker with ritodrine (a beta-2 agonist) may result in mutually antagonistic effects, negating the effect of one or both drugs. | 1 sources — open the full entry |
| Atenolol + Chlorthalidone | Major | Antagonism | The use of a nonselective beta blocker with ritodrine (a beta-2 agonist) may result in mutually antagonistic effects, negating the effect of one or both drugs. | 1 sources — open the full entry |
| Betaxolol Hydrochloride | Major | Antagonism | The use of a nonselective beta blocker with ritodrine (a beta-2 agonist) may result in mutually antagonistic effects, negating the effect of one or both drugs. | 1 sources — open the full entry |
| Bimatoprost + Timolol | Major | Antagonism | The use of a nonselective beta blocker with ritodrine (a beta-2 agonist) may result in mutually antagonistic effects, negating the effect of one or both drugs. | 1 sources — open the full entry |
| Bisoprolol Fumarate | Major | Antagonism | The use of a nonselective beta blocker with ritodrine (a beta-2 agonist) may result in mutually antagonistic effects, negating the effect of one or both drugs. | 1 sources — open the full entry |
| Bisoprolol Fumarate + Amlodipine Besilate | Major | Antagonism | The use of a nonselective beta blocker with ritodrine (a beta-2 agonist) may result in mutually antagonistic effects, negating the effect of one or both drugs. | 1 sources — open the full entry |
| Bisoprolol Fumarate + Hydrochlorothiazide | Major | Antagonism | The use of a nonselective beta blocker with ritodrine (a beta-2 agonist) may result in mutually antagonistic effects, negating the effect of one or both drugs. | 1 sources — open the full entry |
| Brimonidine Tartrate + Timolol Maleate | Major | Antagonism | The use of a nonselective beta blocker with ritodrine (a beta-2 agonist) may result in mutually antagonistic effects, negating the effect of one or both drugs. | 1 sources — open the full entry |
| Brinzolamide + Timolol | Major | Antagonism | The use of a nonselective beta blocker with ritodrine (a beta-2 agonist) may result in mutually antagonistic effects, negating the effect of one or both drugs. | 1 sources — open the full entry |
| Cabozantinib | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that… | 27 sources — open the full entry |
| Carvedilol | Major | Antagonism | The use of a nonselective beta blocker with ritodrine (a beta-2 agonist) may result in mutually antagonistic effects, negating the effect of one or both drugs. | 1 sources — open the full entry |
| Ceritinib | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that… | 27 sources — open the full entry |
| Citalopram Hydrobromide | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that… | 27 sources — open the full entry |
| Clozapine | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that… | 27 sources — open the full entry |
| Crizotinib | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that… | 27 sources — open the full entry |
| Dorzolamide + Timolol | Major | Antagonism | The use of a nonselective beta blocker with ritodrine (a beta-2 agonist) may result in mutually antagonistic effects, negating the effect of one or both drugs. | 1 sources — open the full entry |
| Efavirenz | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that… | 27 sources — open the full entry |
| Escitalopram Oxalate | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that… | 27 sources — open the full entry |
| Esmolol Hydrochloride | Major | Antagonism | The use of a nonselective beta blocker with ritodrine (a beta-2 agonist) may result in mutually antagonistic effects, negating the effect of one or both drugs. | 1 sources — open the full entry |
| Gatifloxacin | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that… | 27 sources — open the full entry |
| Gatifloxacin + Dexamethasone | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that…2 documented mechanisms | 31 sources — open the full entry |
| Haloperidol | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that… | 27 sources — open the full entry |
| Iloperidone | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that… | 27 sources — open the full entry |
| Ivosidenib | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that… | 27 sources — open the full entry |
| Labetalol Hydrochloride | Major | Antagonism | The use of a nonselective beta blocker with ritodrine (a beta-2 agonist) may result in mutually antagonistic effects, negating the effect of one or both drugs. | 1 sources — open the full entry |
| Latanoprost + Timolol | Major | Antagonism | The use of a nonselective beta blocker with ritodrine (a beta-2 agonist) may result in mutually antagonistic effects, negating the effect of one or both drugs. | 1 sources — open the full entry |
| Lefamulin Acetate | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that… | 27 sources — open the full entry |
| Loteprednol Etabonate + Gatifloxacin | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that… | 27 sources — open the full entry |
| Metoprolol Tartrate | Major | Antagonism | The use of a nonselective beta blocker with ritodrine (a beta-2 agonist) may result in mutually antagonistic effects, negating the effect of one or both drugs. | 1 sources — open the full entry |
| Mifepristone | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that… | 27 sources — open the full entry |
| Mifepristone + Misoprostol | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that… | 27 sources — open the full entry |
| Moxifloxacin HydrochlorideInjectionOphthalmicTablet | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that… | 27 sources — open the full entry |
| Moxifloxacin Hydrochloride + Dexamethasone | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that…2 documented mechanisms | 31 sources — open the full entry |
| Moxifloxacin Hydrochloride + Xanthan Gum | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that… | 27 sources — open the full entry |
| Nebivolol + Hydrochlorothiazide | Major | Antagonism | The use of a nonselective beta blocker with ritodrine (a beta-2 agonist) may result in mutually antagonistic effects, negating the effect of one or both drugs. | 1 sources — open the full entry |
| Nebivolol + Valsartan | Major | Antagonism | The use of a nonselective beta blocker with ritodrine (a beta-2 agonist) may result in mutually antagonistic effects, negating the effect of one or both drugs. | 1 sources — open the full entry |
| Nebivolol Hydrochloride | Major | Antagonism | The use of a nonselective beta blocker with ritodrine (a beta-2 agonist) may result in mutually antagonistic effects, negating the effect of one or both drugs. | 1 sources — open the full entry |
| Nilotinib | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that… | 27 sources — open the full entry |
| Osimertinib | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that… | 27 sources — open the full entry |
| Propranolol Hydrochloride | Major | Antagonism | The use of a nonselective beta blocker with ritodrine (a beta-2 agonist) may result in mutually antagonistic effects, negating the effect of one or both drugs. | 1 sources — open the full entry |
| Ribociclib | Major | Synergy | Ribociclib can cause dose-related prolongation of the QT interval. Theoretically, coadministration with other agents that can prolong the QT interval may… | 16 sources — open the full entry |
| Selpercatinib | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that… | 27 sources — open the full entry |
| Sotalol Hydrochloride | Major | Antagonism | The use of a nonselective beta blocker with ritodrine (a beta-2 agonist) may result in mutually antagonistic effects, negating the effect of one or both drugs. | 1 sources — open the full entry |
| Sparfloxacin | Major | Synergy | Beta-2 adrenergic agonists can cause dose-related prolongation of the QT interval and potassium loss. Theoretically, coadministration with other agents that… | 27 sources — open the full entry |
| Timolol Maleate | Major | Antagonism | The use of a nonselective beta blocker with ritodrine (a beta-2 agonist) may result in mutually antagonistic effects, negating the effect of one or both drugs. | 1 sources — open the full entry |
This source documents no food, condition or duplication entries for Ritodrine Hydrochloride.